LEVETIRACETAM DEXCEL 750

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

LEVETIRACETAM

제공처:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC 코드:

N03AX14

약제 형태:

TABLETS

구성:

LEVETIRACETAM 750 MG

관리 경로:

PER OS

처방전 유형:

Required

Manufactured by:

DEXCEL LTD, ISRAEL

치료 그룹:

LEVETIRACETAM

치료 영역:

LEVETIRACETAM

치료 징후:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

승인 날짜:

2018-03-31